London, United Kingdom, (26th January, 2012) – One of the country’s leading providers of medical interviews and interview skills consultancy services, ISC Medical, comments on how the new consultant recruitment process will impact trainees and established consultants.

Since the inception of MMC (Modernising Medical Careers) in 2007, the controversies surrounding the new recruitment process have been overshadowed by the drama caused by the Health and Social Care bill. In February 2012, trainees who joined MMC in 2007 will start to become eligible for consultants posts.

ISC Medical reports that some believe that the new trainees may be in for a rough ride as they compete against established consultants, whilst others feel that the new trainees may instead have the upper hand on their older counterparts since many trusts are actually looking for cheaper clinical resources.

Olivier Picard, MD of ISC Medical, commented: “In an era where current reforms are the central point of discussion, many of the interviews for consultants’ positions will be centred on the candidates’ understanding of those reforms and how they impact on the candidates’ speciality.

“Established consultants may be able to offer greater insight and wisdom, whilst current trainees will need to ensure that they are fully up to date on current NHS issues. As such, attending management and leadership courses for doctors are likely to make a huge difference to individual performances at the interview stage.”

For more information about ISC Medical’s medical courses, visit http://www.medical-interviews.co.uk/ or call 0845 226 9487 between 8:30am and 8:30pm.

About ISC Medical:
ISC Medical is one of the UK’s longest-established companies specialising in medical interview courses, medical CV writing, and medical personal development courses, including teach the teacher courses, for all grades medical school entry, FY, CT/ST, GPST, consultants, and GP posts. They provide a personal service and insist on running all courses in smaller groups, enabling their trainers to accommodate for the individual needs of each client.

Contact:
Olivier Picard
Interview Skills Consulting Ltd,
97 Judd Street,
London, United Kingdom,
Zip: WC1H 9JG
Tel: 0845 226 9487
Email: enquiries@iscmedical.co.uk

ListFree.org: Embedded data.

Excess fat in the thighs can be efficiently removed and your legs contoured perfectly with inner thigh liposuction. A leading cosmetic surgery center in Greenwich, Connecticut, Greenwich Smartlipo offers inner thigh liposuction for men and women. The procedure is performed by Dr. Sandra Margoles and Dr. Elsa Raskin; both experienced plastic surgeons, certified by the American Board of Plastic Surgery.

The procedure can remove unwanted fat from the thighs – giving a more attractive balance and symmetry to the body. Moreover, it also reduces the physical discomfort caused by the frequent rubbing of the thighs. Greenwich Smartlipo uses the most advanced laser liposuction technology to perform the procedure – Smartlipo Triplex. The FDA approved laser lipolysis device Smartlipo Triplex utilizes three laser wavelengths in one output (1440 nm, 1320 nm, and 1064 nm). This triple-wavelength laser system removes extra fat, tightens the skin, and reduces sagging in the inner thigh region.

Smartlipo Triplex laser liposuction technique has gained wide acceptance among patients and physicians alike. The device is most notable for its ability to target fat cells that are often extremely difficult to remove through workout programs. To ensure greater safety and minimal complications, the device features SmartSense™, ThermaView™, and ThermaGuide™ delivery systems.

Smartlipo allows plastic surgeons at Greenwich Smartlipo to offer patients less invasive inner thigh liposuction with faster healing and little or no downtime. The procedure requires only small incisions and has far fewer side-effects compared to traditional liposuction surgery. The plastic surgeons at Greenwich Smartlipo say, “We provide personalized treatments taking into account the patient’s body type, skin quality, and specific treatment goals. We are committed to your satisfaction and offer you natural plastic surgery of the highest quality with personalized care.”

About Greenwich Smartlipo

Greenwich Smartlipo is a leading plastic surgery center conveniently located at Greenwich, Connecticut. Apart from Smartlipo laser liposuction procedures, this plastic surgery center provides a complete line of customized cosmetic procedures to help patients enhance their natural appearance. The surgeons use proven techniques to achieve the cosmetic goals of their patients. For more information, visit http://www.greenwichsmartlipo.com/inner-thigh-liposuction.php

Contact Details

Greenwich Smartlipo
2 ½ Dearfield Dr Suite 102
Greenwich, CT 06831
Phone : 203-769-1200
URL : http://www.greenwichsmartlipo.com

ListFree.org: Embedded data.

Today, a number of people look to teeth whitening to brighten and improve their smile. This could be for a number of different reasons – some people may have stained teeth that they want to bleach while others may simply want to make their teeth brighter and whiter. Unfortunately, many people often get taken in by claims of one-visit fast bleaching techniques which may not work. Dr. Redd’s office believes that a patient can get whiter teeth, provided they approach the process in the right manner.

No Short Cuts

Dr. Redd believes that when it comes to Tampa teeth whitening, it’s important to understand that the bleaching process can’t happen overnight or in a single visit. While it is possible to have a brighter and whiter smile, it’s important for people to understand the different steps that are involved. The Zoom tooth whitening process has proven results and is even used on popular programs like Extreme Makeover. Dr. Redd walks patients through the different steps of this whitening process, so that they can get a better understanding of just how it works.

The first step of the Zoom tooth whitening procedure involves a conditioning process, where the teeth are bleached in the practitioner’s office. This is done in order to allow the teeth to absorb more oxygen from the bleaching gels that are used later. Dr. Redd explains that there won’t be any significant color change after this first bleaching session. He goes on to explain that this conditioning is important because the oxygen that is absorbed during the bleaching process helps to deep-clean the teeth and open up the pores. After this first conditioning visit, Dr. Redd’s team of dentists Tampa Florida will walk the patient through the at-home bleaching process, which involves wearing special bleaching trays for 14 nights.

What to Expect

Dr. Redd doesn’t simply focus on the different steps involved in the Zoom tooth whitening process; he also prepares the patient for the different changes that will occur. Understanding what these changes mean can make it easier to deal with the entire bleaching process. For instance, Dr. Redd explains that it is natural to have sore gums and teeth for the first four days. It is also natural for the teeth to have white spots in some areas while appearing dark near the gum line. This is part of the bleaching process and will even out when the whitening procedure is over. Dr. Redd believes that it is quite possible to have a whiter smile with this process. He also believes it’s important for patients to know the different stages of the process and why it is important to follow the instructions carefully.

To learn more about the Zoom tooth whitening process, you can visit the site www.tampasmiles.com. Information is available on the site regarding this and a number of other dental procedures. Patient forms are also available online. You can mail Dr. Redd at drredd@tampasmiles.com or you can mail the office staff at staff@tampasmiles.com. You can also get in touch at 907 West Platt Street, Tampa, FL 33607, call 813-200-8338 or send a fax to 813-250-0081.

ListFree.org: Embedded data.

Bharatbook added a new report on "Pharmaceutical Brand PR: Developing
Engaging Campaigns and Measuring ROI, FirstWord goes directly to the experts to
determine key factors in what makes PR campaigns buzz. "

The value of PR can seem immeasurable in brand positioning. Yet, in an age of
budgetary juggling by marketing departments, the drive to scrutinize ROI is
increasingly important. What’s more, as expectations on PR outcomes increase—in
part due to social media—its role is broadening. A trend towards using key
performance indicators to measure previously difficult-to-define notions of
success is emerging.

http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/pharmaceutical-brand-pr-developing-engaging-campaigns-and-measuring-roi.html

Report Overview
In Pharmaceutical Brand PR: Developing Engaging Campaigns and Measuring ROI,
FirstWord goes directly to the experts to determine key factors in what makes PR
campaigns buzz and how tightened budgets but greater expectations have changed
the way PR work is mandated. The report also examines the role of PR versus
advertising and how, through social media, PR has become increasingly
sophisticated to position brands across multiple channels and audiences. But
mostly compelling, it dissects why—and how—ROI can be measured and how such
information can deliver more insight than just numbers.
market research book

Key features
* Examination of strategies for measuring ROI in PR campaigns
* PR’s evolution in engaging multiple audiences and working for a brand
* Detailed research into what works—and what doesn’t—in PR
* The role of social media in PR and ROI measurement
* Insight into what other benefits ROI offers
* Experts views on the role of PR versus advertising and if the ratio should
change

Key Benefits
* A full breakdown of the role of PR in the marketing mix
* Clear insight into quantifying ROI and developing measurement criteria
* Access to expert opinion from key leaders in the industry

For more information kindly visit :  Pharmaceutical
Brand PR: Developing Engaging Campaigns and Measuring ROI

Or   

Contact us at :

Bharat Book Bureau
Ph.: +91 22 27810772 / 27810773
Fax: 0091 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter:

http://twitter.com/#!/Sandhya3B

ListFree.org: Embedded data.

Bharatbook added a new report on "Pharma Marketing Excellence: Lessons from
Experience, FirstWord reviews the role of marketing excellence strategies, what
they entail and why they have been integrated into the wider landscape of
competency development "

Marketing excellence. Over the past five years, those two words have been the
subject of hype and the focus of management attention. As the pharmaceutical
industry struggles with market maturation and weakening product pipelines,
marketing excellence programmes have been developed and implemented with an eye
to overcoming those hurdles.

http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/pharma-marketing-excellence-lessons-from-experience.html

But how well are they working and is there one optimal model for their use?
There is no question that such programmes are costly—even low-cost examples have
a high ‘opportunity cost’. In balancing those costs with benefit, the past five
years have yielded important lessons that will now influence the future of
marketing excellence. market research book

Report Overview
In Pharma Marketing Excellence: Lessons from Experience, FirstWord reviews
the role of marketing excellence strategies, what they entail and why they have
been integrated into the wider landscape of competency development and marketing
strategies. In reviewing the experiences of five companies, the report reveals a
four-archetype model, establishes seven key lessons for those implementing
programmes and offers real solutions to not only avoid failure, but ensure
success.

Key features
* Five cases studies offering ground-up insight into marketing excellence

* A four-archetype model for programmes and clear explanation of their best fit

* Seven key lessons for executives implementing marketing excellence
* Explanation of implications for companies considering their implementation
* Overview of what marketing excellence strategies involve, their cost and
benefits

Key Benefits
* Full examination of marketing excellence, how it works, why it’s
implemented
* Review of key lessons taken from current and past programmes
* How companies choose programme content and models dependent upon need

Key quotes
“Unfortunately, marketing excellence is often a reaction to a significant
mistake. One firm we worked with was driven to develop a programme focused on
clinical development after a product failed approval, which was of course a very
expensive and avoidable mistake.” – Kurt Kessler, ZS Associates
“Whilst the concepts are, in principle, quite simple, the devil is in the detail
of how it is applied in the context of the real world.” – Wim Souverijns,
Celgene
“It is about more than just being granted a budget and given an objective. The
key to success is to have the senior management team develop a shared vision of
the programme.” – Theo Nieuwenhuis, Boehringer Ingelheim


For more information kindly visit :  Pharma
Marketing Excellence: Lessons from Experience

Or   

Contact us at :

Bharat Book Bureau
Ph.: +91 22 27810772 / 27810773
Fax: 0091 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter:

http://twitter.com/#!/Sandhya3B

ListFree.org: Embedded data.

Bharatbook added a new report on "Payer Agreements: Splitting the Risk,
FirstWord Dossier offers a complete and concise overview of payer schemes by
definition and category. "

Budgets are tight. Payer funding for new products is dwindling. And for
pharmaceutical companies, market access is more and more difficult to attain.
Across the UK, the US, Canada, Australia and parts of Europe, payer schemes are
increasingly de rigueur. Schemes advanced by pharmaceutical companies either aim
to grapple financial issues such as price volume agreements, or they tackle
uncertainty by addressing increased data collection.

http://www.bharatbook.com/market-research-reports/business-forecast-outlook-market-research-report/payer-agreements-splitting-the-risk.html

Report Overview
In Payer Agreements: Splitting the Risk, FirstWord Dossier offers a complete
and concise overview of payer schemes by definition and category. Based on an
array of expert interviews, the report discusses the key drivers behind the
evolution of payer schemes from financial imperatives to market uncertainty.
Most importantly, the report defines—country by country—emerging trends based on
current case studies and tackles the big question: What are the key features
that will ensure success? market research
book

Key features
* Detailed examination of the role of agreements in global pricing,
reimbursement and market access
* Discussion of the drivers for schemes, including HTA and financial challenges
* Country-by-country trends illustrated with case studies
* Expert insight into the role of schemes and their evolution
* Analysis of the pros and cons of agreements

Key Benefits
* Definitions and categories of schemes
* Expert insight from key regulatory bodies
* Comprehensive references to key literature

Key Questions Asked
* What principles should be used in designing schemes?
* When should companies offer risk-sharing agreements?
* How can European risk-sharing be implemented in the US?
* What is the current state of play with schemes globally?
* What changes are likely in the future?

Who Should Read This Report
* Market access directors and managers
* Health economics professionals
* Pharmacoeconomics professionals
* Health Outcomes / Outcomes Research professionals
* Pricing and Reimbursement teams
* Government and regulatory affairs analysts
* Marketing research/business intelligence managers
* Government and regulatory affairs analysts

For more information kindly visit :  Payer
Agreements: Splitting the Risk

Or   

Contact us at :

Bharat Book Bureau
Ph.: +91 22 27810772 / 27810773
Fax: 0091 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter:

http://twitter.com/#!/Sandhya3B

ListFree.org: Embedded data.

Bharatbook added a new report on "Observing Patients Online: the changing
face of research, FirstWord investigates the role online patient communities can
play in observational research to enhance knowledge of how drugs are taken in
the real world."

For years, patients have shouted to be heard. But as online patient communities,
chat rooms and forums have gained popularity—and political clout—their voices
are resonating. Now being used to paint real-world pictures of patient drug use,
data from online patient communities can no longer be ignored or dismissed. “The
history of medicine is that in many respects patients have been left out of the
conversation,” says Brian Loew, president of inspire.com. “I think patient
communities are a real opportunity to fix that.”

http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/observing-patients-online-the-changing-face-of-research.html

Already, data from online patient communities are being used to deepen
understanding of the patient journey through illness, thus improving compliance,
informing patient-centred endpoints for clinical trials and influencing
reimbursement decisions. Such pools of patients are also being deployed to
conduct direct-to-patient clinical research, where patients are recruited and
monitored online, thus eliminating the need for clinical sites and
investigators. In the face of payer skepticism, however, the question is how
fast will it scale up? market research book

Report Overview
In Observing Patients Online: the changing face of research, FirstWord
investigates the role online patient communities can play in observational
research to enhance knowledge of how drugs are taken in the real world. Based on
expert interviews, research and studies, the report examines how the means to
recruit patients online and track their experience via patient-reported outcome
questionnaires and sensors in real-time has the potential to transform how
observational studies are conducted.

Key features
* Who takes the lead in commissioning observational research
* Typical studies being commissioned online
* How healthcare tracking is going mainstream
* Case study of UCB’s partnership with PatientsLikeMe
* Benefits of crowdsourcing: is it the new serendipity?
* The drivers of online observational research

Key Benefits
* Overview of how online patient communities are transforming observational
research
* Access to expert opinion from key leaders in the industry
* Discussion of conventional versus direct-to-patient trials

For more information kindly visit :  Observing
Patients Online: the changing face of research

Or   

Contact us at :

Bharat Book Bureau
Ph.: +91 22 27810772 / 27810773
Fax: 0091 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter:

http://twitter.com/#!/Sandhya3B

ListFree.org: Embedded data.

Bharatbook added a new report on "New Research into Prescribing Practices
comparative effectiveness research (CER) in the US is not only shedding light on
comparing disease treatments."

Every day, doctors make hundreds of decisions. Decisions that affect patient
care, diagnosis, follow up and pharmaceuticals prescribed.  What influences
those choices? When it comes to prescribing habits, says Dr G Caleb Alexander, a
University of Chicago assistant professor of medicine, “this is one of the great
unknowns. It’s pretty tough to accurately identify the sources and magnitude of
influence that guides physician learning.”

http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/new-research-into-prescribing-practices.html

Yet comparative effectiveness research (CER) in the US is not only shedding
light on comparing disease treatments, but prompting detailed examinations of
how doctors make prescribing decisions and the factors that sway them.

Report Overview
In New Research into Prescribing Practices, FirstWord reviews the role of
CER intelligence, the significant gaps it has identified in physician knowledge
and how CER information will shape the way that pharmaceutical firms promote
their products. Based on expert interviews and the latest research, the report
reveals the key factors influencing physician decisions, from formal education,
casual colleague conversations, insurance regulations and government subsidies
to continuing medical education, samples and even patient pressure.
market research book

Key features
* Compelling insight into how pharma can address prescribing trends
* Examination of CERs influence on pharma, patient care and academic detailing

* Expert insight into how new drug promotions can evolve
* Discussion of how promotions can impact doctor-patient relations
* Analysis of why some drugs are overprescribed while others are underutilized

* Charts and tables illustrating compliance, prescribing trends

Key Benefits
* Expert advice on how pharma and CER projects can influence physician
choice
* Insight into the dominant factors affecting prescribing habits

Key quotes
“Armed with this comparative information, doctors and patients can discuss
the pros and cons of medications to come up with one that best fits the
patient’s needs and preferences.” – Dr Carolyn M Clancy, director of AHRQ

CER is “the next stage in an evolution of research and knowledge development in
regard to medical intervention… Embracing CER is regarded as an essential step
for the innovative pharmaceutical industry.” – Marc L Berger, vice-president of
global health outcomes and David Grainger, global public policy director, Eli
Lilly

“It’s pretty tough to accurately identify the sources and magnitude of influence
that guides physician learning. This is one of those great unknowns. We know
that some sources are influential, but discussing exactly how influential and in
what settings is easier said than done.”
– Dr G Caleb Alexander, assistant professor of medicine, University of Chicago

For more information kindly visit :  New
Research into Prescribing Practices

Or   

Contact us at :

Bharat Book Bureau
Ph.: +91 22 27810772 / 27810773
Fax: 0091 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter:

http://twitter.com/#!/Sandhya3B

ListFree.org: Embedded data.

Bharatbook added a new report on "Health Technology Assessment (HTA): a
European perspective, FirstWord examines the current role of HTA in Europe, from
its impact on reimbursement and pricing to market access."

The bottom line: For payers facing tough financial crunches across Europe,
Health Technology Assessment (HTA) is becoming increasingly important. Not only
is HTA influencing reimbursement, it is having an impact on price and market
access.

http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/health-technology-assessment-htaa-european-perspective.html

And it’s not surprising. With greater scrutiny over the clinical and financial
value of drugs, medical devices and procedures, HTA is increasingly being
accepted around the world. The European situation is somewhat different:
existing across multiple borders, the ‘Europeanisation’ agenda of HTA has
sparked debates about European-wide standards, the possibility of a single
agency governing HTA and the need for formalized cooperation.
market research book

Report Overview
In Health Technology Assessment (HTA): a European perspective, FirstWord
examines the current role of HTA in Europe, from its impact on reimbursement and
pricing to market access. The report focuses on the experiences of five European
nations, reviewing the history of HTA and the key agencies in each. Written by
an expert health economist and with insight from experts from NICE, EUnetHTA ,
the EMA and leading pharmaceutical companies, the report reveals the problems,
pitfalls and—most importantly—the potential of a harmonized approach to HTA in
Europe.

Key features
* Detailed examination of the role of HTA in European pricing, reimbursement
and market access
* An overview of the role of HTA in Germany, France, Italy, Spain and the UK
* Country-by-country breakdown of key agencies
* Expert insight into the ‘Europeanisation’ of HTA and its key challenges
* Review of the potential and pitfalls

Key Benefits
* Full overview the role of HTA in Europe
* Insights from experts in the European Medicines Agency, the National Institute
for Health and Clinical Excellence and leading pharmaceutical companies
* Comprehensive references to key literature

Key Questions Asked
* What role does HTA play in pricing, reimbursement and market access?
* What is the current state of play with HTA across Europe?
* What changes are happening in HTA and what is their impact?
* Does one size fit all in terms of transferability and adaptability?
* What are the pitfalls, problems and potential of HTA in Europe?

For more information kindly visit :  Health
Technology Assessment (HTA): a European perspective

Or   

Contact us at :

Bharat Book Bureau
Ph.: +91 22 27810772 / 27810773
Fax: 0091 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter:

http://twitter.com/#!/Sandhya3B

ListFree.org: Embedded data.

Bharatbook added a new report on "Creating value stories that present a
pharmaceutical’s strongest case from a payer perspective is relatively new
territory. "

It’s an increasingly complex question faced by pharma companies when it comes to
creating compelling value stories for payers. With governments tightening purse
strings, generics flooding the market and the industry scrutinised with new
transparency requirements, finding ways to ‘think global and act local’ has
become critical and it is often not clear who is in charge.

http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/creating-compelling-market-access-stories.html

Creating value stories that present a pharmaceutical’s strongest case from a
payer perspective is relatively new territory. Navigating the task means
creating stronger communication channels between the affiliates and the regional
or global centre as well as between R&D and commercial managers.

Report Overview
Creating Compelling Market Access Value Stories addresses the most
challenging questions facing market access by delving into how value stories are
created and managed. The report offers insight into the critical imperatives
surrounding their development and evolution. It discusses payer expectations,
how companies can ensure that all departments work from a market access
viewpoint and addresses practical issues such as testing the message and
ensuring its consistency for each of the various stakeholders.

Key features
* An examination of the rising importance of market access across Europe and
the US
* A review of how value propositions are built and the question of ownership
* The structural challenges companies face in developing cross-functional market
access capabilities
* The importance of payer research in validating and testing the value story
* Managing political developments
* Charts covering European bodies responsible for HTA activities and
country-by-country measures for rational use of medicines in the EU

Key Benefits
* Concise conclusions on developing and implementing value propositions
* A European-focused picture of how market access value stories are developed
* Expert input on everything from payer research to creating communication
channels across multiple company layers

Key Questions Asked
* Why are market access considerations now underpinning every aspect of the
pharmaceutical business?
* What are the major trends in healthcare technology assessment (HTA)?
* How can companies ensure they meet payer needs?
* When should companies test value stories, and how are tests best conducted?
* How can companies ensure consistency in value stories to all stakeholders?
* What is the importance of keeping current with political developments?

For more information kindly visit :  Creating
compelling market access stories

Or   

Contact us at :

Bharat Book Bureau
Ph.: +91 22 27810772 / 27810773
Fax: 0091 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter:

http://twitter.com/#!/Sandhya3B

ListFree.org: Embedded data.

Bharatbook added a new report on "Biobetters: Major Players and Market
Prospects the report reviews the role biosimilars have played, presents the
rationale behind biobetters and how interest is is stirring in their
development."

Even so, interest in biobetters is increasing, since they can and will command
higher prices while providing a significant improvement to the reference drug.
At the forefront of those turning to biobetters are branded pharma, biotech and
large generic companies who have already established themselves in the
biosimilars industry. But will the emerging biobetter industry prove to be more
lucrative than has been the case for biosimilars?

http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/biobetters-major-players-and-market-prospects.html

Report Overview
In Biobetters: Major Players and Market Prospects (2nd edition), FirstWord
describes the biobetters market and how interest has mounted in what is still a
very young market. The report reviews the role biosimilars have played, presents
the rationale behind biobetters and how interest is is stirring in their
development. In addition, the report concisely outlines how companies are
evolving biobetters, the areas of greatest potential and reviews the ‘Achilles
Heel’ of immunogenicity. Based on frontline expert interviews, the report
addresses the question of approval pathways, who the major players are and,
perhaps most importantly, offers a compelling picture of biobetters’ future
prospects. market research book

Key features
* A comprehensive overview of the nascent biobetters market and where it is
going
* An outline of what biobetters are, how they are being developed and what their
likely targets are
* A discussion of the regulatory landscape
* An insight into the biobetters manufacturers of tomorrow
* An overview of optimal strategies for success

Key Benefits
* Access to top expert opinion and insights
* Compelling overview of the biobetters industry
* Frontline reporting on how it’s evolving and who will be the industry leaders

For more information kindly visit :  Biobetters:
Major Players and Market Prospects

Or   

Contact us at :

Bharat Book Bureau
Ph.: +91 22 27810772 / 27810773
Fax: 0091 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter:

http://twitter.com/#!/Sandhya3B

ListFree.org: Embedded data.

PN Magazine, published by the Paralyzed Veterans of America (PVA), has spotlighted UroMed founder Bert Burns and his family as part of their February 2012 issue. The article shares the story of two relationships that bloomed into successful marriages as a means of inspiration and hope for readers who also use wheelchairs.

Burns started UroMed for more than 15 years ago to help serve people with needs similar to his own with disposable catheters, urological and continence care medical supplies. He met his wife, Joy, in 1995. “Having Joy and our twins, William and Emma, makes me the luckiest guy in the world,” Burns says. “I truly have an amazing life.”

Read the article, titled “Love Knows No Bounds” at http://uromed.com/content/PNFeb2012FullStoryV2LOWRES.pdf

Many of UroMed’s employees have a personal connection to understanding their customers’ urinary health and incontinence needs, as 20% of UroMed’s customer care associates either has a disability or has a family member with a disabling condition. Most of UroMed’s customers experience urological or incontinence issues, and have conditions like Spinal Cord Injury, Spina Bifida, Transverse Myelitis or Multiple Sclerosis.

Helpful Links
Bert’s Story: http://www.uromed.com/Company/LifeAfterSpinalCordInjury Life After Spinal Cord Injury Facebook page: http://tinyurl.com/LASCIpage

About PN Magazine
From a six-page newsletter in 1945 to a monthly publication that spans the globe, PN continues to be an invaluable resource for people with spinal-cord injuries, family members, and caregivers alike. Originally, PN was known as Paraplegia News, and during an era where spinal-cord injuries were considered a life-altering tragedy, our mission was clear. Since that time we have seen great strides in technology, public awareness, and the general perceptions concerning people with disabilities. PN embodies the “power” of the spirit, the “professional” contributions to society, the “personal” story within each person, the “practical” resolve to carry on, and even the “playful” nature of the soul. In short – we are PN, and we welcome you to better wheelchair living. http://pvamag.com/pn/

About UroMed
Headquartered in Suwanee, GA [a suburb of Atlanta], UroMed is one of the nation’s leading providers of single-use catheters, urological and disposable medical supplies, including intermittent catheters, closed system catheters, condom catheters, pediatric catheters and continence care products. UroMed is a nationally accredited organization, a Medicare provider and a participant in most state Medicaid plans. UroMed also partners with thousands of private health insurance providers and health plans to provide patients with single-use catheters, catheter kits and incontinence products. UroMed has seven staffed regional offices located in Richmond, VA; Columbia, SC; Jacksonville, FL; Dallas, TX; Carlsbad, CA; Knoxville, TN; and Baton Rouge, LA; enabling next-day delivery after a customer’s initial medical supply order. For more information, please visit http://www.uromed.com or call 1-800-841-1233.

Join more than 6700 friends in our Facebook Spinal Cord Injury peer support community at: http://tinyurl.com/LASCIpage

ListFree.org: Embedded data.

South Nassau Communities Hospital and Hofstra North Shore-LIJ School of Medicine have signed an academic affiliation agreement, which is effective immediately and combines the School of Medicine’s academic and clinical resources with South Nassau’s clinical programs and physicians to provide world class medical training opportunities and facilitate collaboration on leading-edge medical education initiatives.

“This affiliation benefits each institution as well as the communities and patients served by South Nassau,” said Linda Efferen, MD, South Nassau’s chief medical officer. “In addition to training new physicians and providing continuing medical education opportunities for medical staff, it will enhance patient care by fostering research and quality initiatives designed to enhance patient care and improve clinical programs.”

Under the agreement, Hofstra North Shore-LIJ medical students will be offered clinical assignments and training opportunities with South Nassau’s community and hospital-based physicians encompassing ambulatory, in-patient and emergency services.

The affiliation with the new School of Medicine complements South Nassau’s extensive roster of medical education affiliations. The hospital sponsors a three-year, post-graduate Family Practice Residency Program that is affiliated with SUNY Stony Brook Health Science Center and New York College of Osteopathic Medicine as well as a Podiatry Residency Program. It also has an integrated residency program in surgery with Nassau University Medical Center and St. John’s Hospital as well as residency rotations in pediatrics for residents from Cohen’s Children’s Medical Center; in obstetrics and gynecology with Nassau University Medical Center and St. John’s Hospital and in physical medicine and rehabilitation with Nassau University Medical Center. In addition to the new South Nassau agreement with the Hofstra North Shore-LIJ School of Medicine, South Nassau also offers undergraduate clinical experiences for medical students from SUNY at Stony Brook, SUNY at Brooklyn, New York College of Osteopathic Medicine, and Ross University Medical School.

South Nassau Communities Hospital is one of the region’s largest hospitals, with 435 beds, more than 900 physicians and 2,900 employees. Located in Oceanside, NY, the hospital is an acute-care, not-for-profit teaching hospital that provides state-of-the-art care in cardiac, oncologic, orthopedic, bariatric, pain management, mental health and emergency services. In addition to its extensive outpatient specialty centers, South Nassau provides emergency and elective angioplasty and is the only hospital on Long Island with the Novalis Tx™ and Gamma Knife® Perfexion radiosurgery technologies. South Nassau is a designated Stroke Center by the New York State Department of Health and Comprehensive Community Cancer Center by the American College of Surgeons and is recognized as a Bariatric Surgery Center of Excellence by the American Society for Metabolic and Bariatric Surgery. For more information, visit www.southnassau.org.

ListFree.org: Embedded data.

BCC Research’s goal in conducting this study was to determine the present status of the worldwide catheter market and to evaluate its potential over the five-year period from 2011 to 2016. An assessment of the global catheter market was performed while considering all of its important segments (i.e., cardiovascular, urological, neurovascular, intravenous, and specialty catheters).

REASONS FOR DOING THE STUDY
Catheterization procedures have steadily increased as interventional and less-invasive procedures have become more popular. Catheters are vital to the completion of many procedures, and some procedures or interventions, particularly in cardiovascular surgery and neurosurgery, could not be done without the use of catheters. In conducting this study, BCC was interested in determining the areas of catheter applications poised for growth and the reasons for their growth. New products and their future impact on the market were also assessed.

SCOPE OF REPORT
BCC investigated the current catheter market and based projections of total, geographic, and type of product market revenues through 2016 based on current and historical usage, geographical and socio/economic market trends, and new applications and products.
The scope of this study encompasses the six major application segments of the catheter market. BCC Research analyzes each type of catheter segment, determines its current market status, examines its impact on future markets, and presents growth forecasts over the next five years.

Request a Sample for or Inquire before buying the report@
Global Catheter Market EMRA Countries

Report Highlights
The global catheter market was $17.0 billion in 2010 and $21.2 billion in 2011. This global market is projected to increase at a compound annual growth rate (CAGR) of 8.7% reaching a value of $32.1 billion by 2016.
In 2011, the American region of the market accounted for $11.5 billion and is projected to reach $12.0 billion by the end of forecast period in 2016. The CAGR for the Americas is projected to be 0.7% during the period 2011 to 2016.
Catheter sales in the region comprised of Western Europe, Eastern Europe, the Middle East, Russia, and Africa (EMRA), were an estimated $6.6 billion in 2011 and are estimated to grow at a CAGR of 15.6% reaching $13.7 billion by 2016.?

Major points covered in Table of Contents of this report include:
STUDY GOALS AND OBJECTIVES
REASONS FOR DOING THE STUDY
SCOPE OF REPORT
METHODOLOGY
INTENDED AUDIENCE
INFORMATION SOURCES
ANALYST CREDENTIALS
RELATED BCC REPORTS
BCC ONLINE SERVICES

Explore Comprehensive list of more than Tables & Figures available in the report @ http://www.reportsnreports.com/reports/145558-global-markets-for-catheters-focus-on-the-emra-countries.html

Report Details:
Published: January 2012
No. of Pages:
Price: Single User License – US $ 3900
Corporate User License – US $ 6835

ListFree.org: Embedded data.

Bharatbook.com added a new research report on "Surgical Instruments Market
in India 2012" which provides a brief description of surgical instruments and
their uses.

Surgical Instruments Market in India 2012

The medical device market is a thriving segment of the healthcare industry in
India. Rise in the number of hospitals and increasing requirement of healthcare
facilities on account of the changing demographics and increasing lifestyle
diseases is creating a need for medical devices of all types ranging from simple
instruments to the most sophisticated devices and equipments that work on
complex mechanisms. The market for surgical instruments is also showing the same
trend and is growing at a steady pace. Unlike the market for other medical
devices where multinationals dominate, in the case of surgical instruments, a
large number of domestic manufacturers exist. The market is also not import
dependent unlike in the case of most other devices but is an export earner. The
growing target base of consumers is expected to boost sales and the market is
expected to exhibit steady growth in future.

http://www.bharatbook.com/market-research-reports/medical-devices-market-research-report/surgical-instruments-market-in-india-2012.html

The report begins with an introduction section which provides a brief
description of surgical instruments and their uses. The market overview section
provides an insight into the market and highlights the market size and growth. A
section on the import and export of various surgical instruments has been given
in the next section. It provides the value-wise and volume-wise import and
export figures for six different categories of surgical instruments.

This is followed by an analysis of the drivers leading to growth in the market.
This includes increasing surgical procedures, improving hospital infrastructure,
growing medical tourism, increasing lifestyle diseases, changing demographic
structure and increasing healthcare spending. The key challenges that act as an
impediment to growth in this market are improper sterilization procedures and
reluctance to use by medical centers. The next section deals with the various
trends in surgical procedures over the years. These surgical trends include
powered surgical tools, minimally invasive surgeries and robotic surgeries.

The competition section provides an overview of the competitive landscape in the
industry and includes a detailed profile of the major players in the market. The
Porter’s Five Forces analysis for the surgical instruments market is provided in
this section. A summary of the major players operating in the market has also
been provided in the form of a bubble chart. It also includes the list of
products and services, key people, financial snapshot, key ratios and key recent
developments for the major players. For public companies, their key business
segments and key geographic segments have also been provided.

For more information kindly visit : 

http://www.bharatbook.com/market-research-reports/medical-devices-market-research-report/surgical-instruments-market-in-india-2012.html      

Or

Contact us at :

Bharat Book Bureau
Ph.: + 91 22 27810772 / 27810773
Fax: + 91 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter:
http://twitter.com/#!/Sandhya3B

ListFree.org: Embedded data.